Paul V Maier - Net Worth and Insider Trading
Paul V Maier Net Worth
The estimated net worth of Paul V Maier is at least $1 Million dollars as of 2024-04-26. Paul V Maier is the Sr. V-P, CFO of Ligand Pharmaceuticals Inc and owns about 14,159 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $1 Million. Paul V Maier is the Director of Eton Pharmaceuticals Inc and owns about 59,745 shares of Eton Pharmaceuticals Inc (ETON) stock worth over $207,913. Paul V Maier is also the CFO of Sequenom Inc and owns about 63,111 shares of Sequenom Inc (SQNM) stock worth over $150,835. Besides these, Paul V Maier also holds International Stem Cell Corp (ISCO) , MabVax Therapeutics Holdings Inc (MBVXQ) . Details can be seen in Paul V Maier's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul V Maier has not made any transactions after 2019-04-18 and currently still holds the listed stock(s).
Transaction Summary of Paul V Maier
Paul V Maier Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul V Maier owns 10 companies in total, including International Stem Cell Corp (ISCO) , Eton Pharmaceuticals Inc (ETON) , and Ritter Pharmaceuticals Inc (RTTR) among others .
Click here to see the complete history of Paul V Maier’s form 4 insider trades.
Insider Ownership Summary of Paul V Maier
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ISCO | International Stem Cell Corp | 2019-04-18 | director |
| ETON | Eton Pharmaceuticals Inc | 2018-11-15 | director |
| RTTR | Ritter Pharmaceuticals Inc | 2020-01-15 | director |
| MBVXQ | MabVax Therapeutics Holdings Inc | 2018-04-02 | director |
| SEEL | Seelos Therapeutics Inc | 2014-01-02 | director |
| SQNM | Sequenom Inc | 2014-02-10 | Chief Financial Officer |
| PURE | PURE Bioscience Inc | 2008-01-22 | director |
| LGND | Ligand Pharmaceuticals Inc | 2006-11-20 | Sr. V-P & CFO |
| QLGN | Qualigen Therapeutics Inc | 2015-06-24 | director |
| AMAM | Ambrx Biopharma Inc | 2023-06-07 | director |
Paul V Maier Latest Holdings Summary
Paul V Maier currently owns a total of 5 stocks. Among these stocks, Paul V Maier owns 14,159 shares of Ligand Pharmaceuticals Inc (LGND) as of November 20, 2006, with a value of $1 Million and a weighting of 73.56%. Paul V Maier owns 59,745 shares of Eton Pharmaceuticals Inc (ETON) as of November 15, 2018, with a value of $207,913 and a weighting of 15.21%. Paul V Maier also owns 63,111 shares of Sequenom Inc (SQNM) as of August 1, 2012, with a value of $150,835 and a weighting of 11.04%. The other 2 stocks International Stem Cell Corp (ISCO) , MabVax Therapeutics Holdings Inc (MBVXQ) have a combined weighting of 0.19% among all his current holdings.
Latest Holdings of Paul V Maier
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2006-11-20 | 14,159 | 71.01 | 1,005,360 |
| ETON | Eton Pharmaceuticals Inc | 2018-11-15 | 59,745 | 3.48 | 207,913 |
| SQNM | Sequenom Inc | 2012-08-01 | 63,111 | 2.39 | 150,835 |
| ISCO | International Stem Cell Corp | 2019-04-18 | 31,710 | 0.08 | 2,537 |
| MBVXQ | MabVax Therapeutics Holdings Inc | 2015-05-29 | 225 | 0.02 | 5 |
Holding Weightings of Paul V Maier
Paul V Maier Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul V Maier has made a total of 0 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 4,503 shares on November 20, 2006, which brought Paul V Maier around $308,793.
According to the SEC Form 4 filings, Paul V Maier has made a total of 0 transactions in Eton Pharmaceuticals Inc (ETON) over the past 5 years. The most-recent trade in Eton Pharmaceuticals Inc is the acquisition of 5,000 shares on November 15, 2018, which cost Paul V Maier around $30,000.
According to the SEC Form 4 filings, Paul V Maier has made a total of 0 transactions in Sequenom Inc (SQNM) over the past 5 years. The most-recent trade in Sequenom Inc is the acquisition of 10,000 shares on August 1, 2012, which cost Paul V Maier around $28,600.
More details on Paul V Maier's insider transactions can be found in the Insider Trading History of Paul V Maier table.Insider Trading History of Paul V Maier
- 1
Paul V Maier Trading Performance
GuruFocus tracks the stock performance after each of Paul V Maier's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul V Maier is -0.92%. GuruFocus also compares Paul V Maier's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul V Maier within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul V Maier's insider trading performs compared to the benchmark.
Performance of Paul V Maier
Average Return
-25.15%
Outperforming Transactions
33%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.62 | -0.92 | 8.38 | -25.15 | -15.02 | -26.09 |
| Relative Return to S&P 500(%) | 11.24 | -0.87 | 3.84 | -37.81 | -28.36 | -40.55 |
Paul V Maier Ownership Network
Ownership Network List of Paul V Maier
Ownership Network Relation of Paul V Maier
Paul V Maier Owned Company Details
What does International Stem Cell Corp do?
Who are the key executives at International Stem Cell Corp?
Paul V Maier is the director of International Stem Cell Corp. Other key executives at International Stem Cell Corp include 10 percent owner Andrei Semechkin , Dir. of Legal Affairs & Oper. Sofya Bakalova , and Acting Chief Financial Officer Jennifer Stephens .
International Stem Cell Corp (ISCO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of International Stem Cell Corp (ISCO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of International Stem Cell Corp (ISCO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
International Stem Cell Corp (ISCO)'s detailed insider trading history can be found in Insider Trading Tracker table.
International Stem Cell Corp Insider Transactions
Paul V Maier Mailing Address
Above is the net worth, insider trading, and ownership report for Paul V Maier. You might contact Paul V Maier via mailing address: 3595 John Hopkins Court, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
